The biotech is floating a fresh issue of its common stock. Certain participants will be sold warrants in lieu of equity. The company aims to raise gross proceeds of roughly $300 million in a new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback